Targeted breast screening could reduce overdiagnosis and be more cost effective, study finds

Main|Search|PHGKB


Last Posted: Jul 07, 2018

---

• Targeted breast screening could reduce overdiagnosis and be more cost effective, study finds  
  BMJ News, July 2018
• Surgeons Influence Receipt of Genetic Testing After Breast Cancer Diagnosis  
  N Fawcett, University of Michigan Health Lab Blog, July 3, 2018
• Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer A Life-Table Model  
  N Pashayan et al, JAMA Oncology, Juy 5, 2018
• [Preventive contralateral mastectomy despite absence of gene mutation; management and treatment of women with no medical indication].  
  de Jong L et al. Nederlands tijdschrift voor geneeskunde 2017 161(0) D432
• A randomized controlled trial of a Supportive Expressive Group intervention for Women with a Family History of breast Cancer.  
  Esplen Mary Jane et al. Psycho-oncology 2018 Jun
• Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.  
  Katz Steven J et al. JAMA surgery 2018 Jul
• Bone loss in women with BRCA1 and BRCA2 mutations.  
  Powell C Bethan et al. Gynecologic oncology 2018 148(3) 535-539
• Clinicopathologic Characterization of Breast Carcinomas in Patients with Non-BRCA Germline Mutations: Results from a Single Institution's High Risk Population.  
  Meiss Alice E et al. Human pathology 2018 Jun
• Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.  
  Pashayan Nora, et al. JAMA oncology 2018 7 0.
• Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.  
  Grimmett Chloe et al. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2018 Jun

more